#1 Clinical Trials Search in Europe

Fluticasone Furoate

This article summarizes key findings from clinical trials investigating the use of fluticasone furoate, an inhaled corticosteroid, for treating asthma and chronic obstructive pulmonary disease (COPD). The trials examined the drug’s effectiveness, safety profile, and potential benefits compared to other treatments or placebos in improving lung function, reducing exacerbations, and enhancing quality of life for patients with these respiratory conditions.

Table of Contents

What is Fluticasone Furoate?

Fluticasone furoate is a medication used to treat respiratory conditions, primarily asthma. It belongs to a class of drugs called corticosteroids, which help reduce inflammation in the airways[1]. Fluticasone furoate is also known by brand names such as Arnuity Ellipta[2].

Uses and Conditions Treated

Fluticasone furoate is primarily used to treat:

  • Asthma: It helps control persistent asthma in adults and adolescents[1].
  • Childhood Obstructive Sleep Apnea Syndrome (OSAS): Some studies have investigated its use in treating this condition in children[3].

How Fluticasone Furoate Works

Fluticasone furoate works by reducing inflammation in the airways. When you inhale the medication, it goes directly to your lungs where it helps to:

  • Decrease swelling and irritation in the airways
  • Reduce mucus production
  • Make breathing easier

By reducing inflammation, fluticasone furoate helps prevent asthma symptoms and attacks[1].

How It’s Administered

Fluticasone furoate is typically administered as an inhalation powder. It’s often used with a special inhaler device called ELLIPTA[2]. The medication is usually taken once daily, which is different from some other asthma medications that need to be taken multiple times a day[1].

Effectiveness

Clinical trials have shown that fluticasone furoate can be effective in managing asthma. Some key findings include:

  • Improved lung function: Studies have shown that fluticasone furoate can improve FEV1 (Forced Expiratory Volume in 1 second), which is a measure of how much air a person can exhale in one second[1].
  • Reduced need for rescue medication: Patients using fluticasone furoate often had more days where they didn’t need to use their rescue inhaler[1].
  • Improved quality of life: Some studies measured improvements in patients’ quality of life using specialized questionnaires[1].

Potential Side Effects

While fluticasone furoate is generally considered safe, like all medications, it can have side effects. Some potential side effects include:

  • Throat irritation
  • Headache
  • Respiratory infections

In some studies, researchers specifically looked for the occurrence of pneumonia as a potential side effect[2]. It’s important to discuss any side effects with your healthcare provider.

Ongoing Research

Researchers continue to study fluticasone furoate to better understand its effects and potential uses. Some areas of ongoing research include:

  • Combination therapies: Studies are looking at combining fluticasone furoate with other medications, such as vilanterol (a long-acting beta2-agonist), to potentially improve asthma control[4].
  • Use in children: While fluticasone furoate is approved for use in adults and adolescents, research is ongoing to understand its effects in younger children[5].
  • Effects on airway responsiveness: Some studies are investigating how fluticasone furoate affects the airways’ response to irritants[6].
Aspect Details
Drug Name Fluticasone Furoate
Drug Type Inhaled corticosteroid
Conditions Studied Asthma, Chronic Obstructive Pulmonary Disease (COPD)
Administration Method Inhalation powder via dry powder inhaler
Dosing Frequency Typically once daily
Key Outcomes Measured Lung function (FEV1, PEF), exacerbation rates, symptom-free days, quality of life
Comparators Placebo, other inhaled corticosteroids (e.g., fluticasone propionate)
Combination Therapies Often studied in combination with long-acting beta agonists (e.g., vilanterol)
Safety Considerations Adverse events, long-term safety outcomes, effects on cortisol levels
Patient Populations Adults and adolescents with asthma or COPD, varying disease severities

FAQ

  • What is fluticasone furoate? Fluticasone furoate is an inhaled corticosteroid medication used to treat asthma and chronic obstructive pulmonary disease (COPD). It works by reducing inflammation in the airways to help improve breathing.
  • How is fluticasone furoate administered? Fluticasone furoate is typically administered as an inhalation powder using a dry powder inhaler device. In the clinical trials, it was often given once daily, either alone or in combination with other medications.
  • What were the main outcomes measured in the fluticasone furoate trials? The trials measured outcomes such as lung function (FEV1), frequency of asthma exacerbations, use of rescue medications, symptom-free days, quality of life scores, and safety indicators like adverse events.
  • How does fluticasone furoate compare to placebo? Several trials showed that fluticasone furoate improved lung function, reduced exacerbations, and increased symptom-free days compared to placebo in patients with asthma or COPD.
  • Are there any side effects associated with fluticasone furoate? While generally well-tolerated, some potential side effects monitored in the trials included throat irritation, headache, and upper respiratory tract infections. The trials also assessed long-term safety outcomes.

Ongoing Clinical Trials on Fluticasone Furoate

  • Study comparing fluticasone furoate and vilanterol inhalation powder with BREO ELLIPTA in adults with asthma to evaluate their therapeutic equivalence and safety

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • A study testing dust mite allergy extracts from Dermatophagoides pteronyssinus and Dermatophagoides farinae for patients with allergic rhinoconjunctivitis with or without controlled asthma

    Not yet recruiting

    3 1 1
    Investigated drugs:
    Spain

  • Study Comparing Trelegy with LABA-LAMA Drug Combination for Improving COPD Control in High-Risk Patients

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on Asthma Control and Adherence with Mepolizumab in Pre-filled Devices for Patients with Asthma

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Effects of Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

    Not recruiting

    3 1 1
    Investigated drugs:
    Germany

Glossary

  • FEV1: Forced Expiratory Volume in 1 second – the maximum amount of air a person can forcefully exhale in one second. It's a key measure of lung function used to assess the severity of conditions like asthma and COPD.
  • Peak Expiratory Flow (PEF): The maximum rate of airflow achieved during a forced exhalation starting with fully inflated lungs. It's often measured using a peak flow meter to monitor asthma control.
  • Exacerbation: A worsening of symptoms in a chronic disease like asthma or COPD, often requiring additional treatment or hospitalization.
  • Bronchodilator: A medication that relaxes and opens the airways in the lungs, making breathing easier. Often used as 'rescue' medication for quick symptom relief.
  • Inhaled Corticosteroid (ICS): A type of anti-inflammatory medication inhaled directly into the lungs to reduce airway inflammation in conditions like asthma and COPD.
  • Long-Acting Beta Agonist (LABA): A type of bronchodilator medication that works over an extended period to relax and open airways. Often combined with inhaled corticosteroids for asthma and COPD treatment.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare against the effects of the active drug being studied.
  • Spirometry: A lung function test that measures how much and how quickly air can be inhaled and exhaled. It's commonly used to diagnose and monitor respiratory conditions.
  • Asthma Control Questionnaire (ACQ): A standardized set of questions used to assess the level of asthma control in patients over a specified period.
  • Quality of Life Questionnaire: A survey tool used to measure the impact of a medical condition or treatment on a person's overall well-being and daily functioning.

References

  1. https://clinicaltrials.gov/study/NCT01159912
  2. https://clinicaltrials.gov/study/NCT03184480
  3. https://clinicaltrials.gov/study/NCT00603044
  4. https://clinicaltrials.gov/study/NCT03363191
  5. https://clinicaltrials.gov/study/NCT01453023
  6. https://clinicaltrials.gov/study/NCT03898466